Designing nanofibrous poly(ε-caprolactone)/hydroxypropyl cellulose/zinc oxide/Melilotus Officinalis wound dressings using response surface methodology.

Drug release Electrospun nanofibers Hydroxypropyl cellulose (HPC) Melilotus Officinalis (MO) extract Poly(ε-caprolactone) Wound dressing Zinc oxide nanoparticles (ZnO)

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
15 Dec 2022
Historique:
received: 15 08 2022
revised: 17 10 2022
accepted: 21 10 2022
pubmed: 30 10 2022
medline: 3 12 2022
entrez: 29 10 2022
Statut: ppublish

Résumé

Nanofibrous wound dressing is one of the most prominent stratagems for wound caring/management. This research is an approach for designing an electrospun wound dressing based on poly(ε-caprolactone)/hydroxypropyl cellulose/zinc oxide nanoparticles (PCL/HPC/n-ZnO), in which response surface methodology (RSM) was utilized to ascertain the optimum sample. It was observed that the addition of n-ZnO and Melilotus Officinalis (MO) extract could increase the fibers mean diameter, pore size, and crystallinity of mats. The mentioned quantities for a sample with the highest MO content (PHZM10) were equal to 469±105 nm, 544±370 nm, and 49.67%, respectively. Moreover, enhancing the amount of MO led to an increase in mechanical properties. In this respect, the PHZM10 sample had the modulus, strength, and toughness of 82.41±0.61, 20.45±0.30 MPa, and 4194.86 mJ, respectively. Also, according to the MTT assay, no cytotoxicity was reported from any of the manufactured samples. Besides, it was concluded that the antibacterial activity and nanofibrous structure of mats, and also their potential for release of MO extract could accelerate the wound healing. Hence, the wound closure index for the PHZM10 group was 99.3±1.1%. Based on all noted results, the PCL/HPC/n-ZnO/MO electrospun mats can be proposed as reassuring wound dressing candidates.

Identifiants

pubmed: 36309291
pii: S0378-5173(22)00893-6
doi: 10.1016/j.ijpharm.2022.122338
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
caprolactone 56RE988L1R
hydroxypropylcellulose 9XZ8H6N6OH
Plant Extracts 0
polycaprolactone 24980-41-4
Zinc Oxide SOI2LOH54Z

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122338

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mohammad Shahrousvand (M)

Polymer Engineering Department, Chemical Engineering Faculty, Tarbiat Modares University, Tehran Iran. Electronic address: mohammadshahrousvand@yahoo.com.

Nadereh Golshan Ebrahimi (N)

Polymer Engineering Department, Chemical Engineering Faculty, Tarbiat Modares University, Tehran Iran. Electronic address: ebrahimn@modares.ac.ir.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans China Cerebral Hemorrhage Patient Care Bundles Length of Stay

Classifications MeSH